Vital Paid $27 Million for Certainty — and Brazil Is Doing the Rest
Vital Infrastructure Property Trust reported its third quarter on 12 November with a portfolio that is objectively performing — same-property NOI up 3.5% ex-outsourcing, 97% occupancy, $357 million of liquidity — and a NAV that fell anyway. NAV per unit slipped to $7.43 from $7.66. The gap between those two facts is the whole story of this quarter: one long-running problem was solved at a real, quantifiable cost, and a second one management insists is immaterial became the thing the market actually traded.
The most expensive good news of the year
For six quarters, the Australian situation has hung over this portfolio. This quarter it resolved: creditors approved the sale of Healthscope's remaining hospital operations, and Calvary Healthcare becomes the new tenant across all twelve properties. On the prior call, Stephanie Karamarkovic declined to put numbers on the terms — “at this time, we are not able to comment again given the terms of the transaction” — Stephanie Karamarkovic, Chief Financial Officer · 2026-08-13 — so we are now learning what the silence was worth. The structure includes “rent incentives over the first 48 months of the lease, an extended lease term that brings the portfolio WALE to approximately 18 years” — Zachary Vaughan, Chief Executive Officer · 2026-11-12, plus enhanced indexation and a future rent review mechanism tied to property-level profitability.
The accounting told the truth the press release did not. Karamarkovic itemised it plainly: “fair value adjustments from the revised Calvary lease terms, which was a $7.5 million reduction at our share of the Australian hospital properties and a $19 million reduction in our management platform valuation” — Stephanie Karamarkovic, Chief Financial Officer · 2026-11-12 — about $27 million of NAV between them. A resolution that reads as a win is economically a deferral: front-loaded incentives in exchange for an eighteen-year lease and an option on future Australian operator margins. That option is not worthless. The hospital benefit ratio sits near 86% versus a pre-pandemic 90%, and every point of normalisation flows into that rent review. But it is a call option, not rent, and the NAV paid for it today.
Brazil: an asset-backed bond trading like an EM equity
The post-election move in the Brazilian assets dominates the Q&A — five of the first six questions, from four different analysts. Management's defence is unusually quantitative. The portfolio is 100% leased to Rede D'Or on triple-net uncapped inflation-linked contracts, and the 4-wall coverage is the number Zach Vaughan wants investors to anchor on:Realty Income, the largest U.S. net lease REIT ... typically cites 4-wall coverage in the 2.5 to 3x range. Across our Brazilian portfolio, our 4-wall coverage sits at approximately 7x.
He is right that a tenant covering rent seven times over is not a credit problem, and the market data corroborates him: Rede D'Or spreads did not move post-election and are down roughly 20 basis points year-over-year. The global recent elections keyword cracked the top-50 market-wide this quarter on the back of exactly this kind of EM repricing, and Brazilian financials in the global tape have been hit across the 30-day window. So the Brazil discount is a currency and sentiment discount, not a cash-flow discount — and management is candid that they cannot fix it. Hedging the real is, per the CFO, “quite punitive to try to hedge the Brazilian real through kind of any kind of derivative” — Stephanie Karamarkovic, Chief Financial Officer · 2026-11-12, and local debt is a non-starter with rates at 13-14%. The hedge is effectively the structure of the lease itself.
Two items deserve more attention than they got. First, the 8.9% Brazilian cap rate was not marked to the post-election world; Vaughan concedes the implied discount rate of roughly 8.5% is now wide of NTN-B inflation-linked yields near 7.8% (they began the year at 7.5%, dipped to 6.8%, and have round-tripped), and that they will revisit it in Q4 — a live NAV risk that has not yet been taken. Second, the exit has quietly become open-ended. Brazil was never in the twelve-month recycling plan, and with the assets described as an inflation linked bond that is simply yielding wide, there is no forcing function.
The balance sheet rewrite — and the buyback dilemma
The financing work this quarter is genuinely best-in-class for a company this size. A new $500 million unsecured credit facility replaced the secured line and pushed maturity to 2031; an unsecured debenture offering of $300 million at 4.865% retired the 6.25% Series H converts and eliminated an August 2027 maturity. Unencumbered assets went from $1.2 billion to $2.1 billion in nine months, and the credit spread came more than 100 basis points inside the inaugural issue. That is the financial flexibility story working exactly as pitched.Buried in it is a nice irony: the economic weighted average interest rate rose to 5.33% from 4.71% — not because anything got worse, but because cheap European mortgages were repaid. Leverage sits at 49.9% debt-to-GBV and 8.5x EBITDA, at the bottom of the 8-9x band. AFFO of $0.10 was a penny light year-over-year on timing of redeployment and the $1.6 million deconsolidation drag from Vital Trust, with the payout ratio at 89% versus 85%.
The capital allocation tension is real and management does not hide it. They renewed the NCIB for roughly 22 million units and $8.5 million of Series I converts even as they chase acquisitions — “it's competing with new acquisitions” — Zachary Vaughan, Chief Executive Officer · 2026-11-12. With $170 million closed in Brooklyn, Burlington and Edmonton and roughly $250 million targeted for the year, and yields on U.S. deals now “100 basis points wide of that today” — Zachary Vaughan, Chief Executive Officer · 2026-11-12 versus the low-to-mid 6s they underwrote earlier, the capital recycling machine is the higher-return use of cash — provided they can keep feeding it.
The timeline is sliding, quietly
In August, Vaughan was explicit: “in 24 months, we will be pretty much Americas, North America focused” — Zachary Brian Vaughan, Chief Executive Officer · 2026-08-13. Three months later the map has stretched. Europe's German clinic portfolio is now framed as a Q2 2027 event with the Rotterdam asset another six to nine months behind (“every transaction just takes longer” — Zachary Vaughan, Chief Executive Officer · 2026-11-12); Australia is end-2027 into 2028 because the new tenant must season; and Brazil has no date at all. The available liquidity lever that makes this tolerable is the Vital Trust unit stake — about CAD 70 million of debt against it — which management calls the easiest source of capital. It is also worth remembering the CFO's note that exiting a full region carries roughly 15% tax leakage, already baked into IFRS.One small tell: New York was one of this company's hottest keywords last quarter; this quarter it flipped into the decliner column even as a Brooklyn acquisition closed. The narrative weight inside this portfolio has moved south. Watch Q4 for the Brazilian cap-rate mark, the first Calvary rent under the incentive schedule, and whether the buyback or another U.S. outpatient portfolio wins the marginal dollar.